News

According to the deal, Novo Nordisk has access to the Kymouse HK and Kymouse HL transgenic human antibody mouse strains, the combination of which are used to create

Lonza will manufacture BNC101 at Slough facility in the UK. Bionomics CEO and managing director Dr Deborah Rathjen said, "The start of manufacturing activities for BNC101 signals a

Alitair provided additional details regarding its ‘398 patent specific to formulations of benzonatate. At present, benzonatate is the only non-narcotic prescription cough product available, according to the company

The novel chemical entity XEN402 is designed to inhibit the SCN9A sodium channel. Teva Pharmaceutical Industries has exclusive worldwide license to XEN402 that earlier demonstrated to relieve from

Ideal for both upstream and downstream processing, the HyPerforma SUM DS 300 system enables producers to meet liquid production demands with a minimal capital investment. The HyPerforma SUM

As per the development collaboration, Activaero’s FAVORITE (Flow and Volume Controlled Inhalation Technology) inhalation approach will be used along with an undisclosed compound to treat PH. The program

The study will assess the safety and efficacy profile of a once-daily oral combination regimen comprising Bristol-Myers’ investigational NS5A replication complex inhibitor daclatasvir and Merck’s investigational NS3/4A protease

As per the agreement, Phyto Nutricare will pay a one-time license fee of $2m to Plandai and then a recurring payment of 5% from the future profits of

As per the agreement, DSM will initiate the development activities for DecImmune’s lead monoclonal antibody program. DecImmune is developing an antibody-based therapeutic that can prevent tissue damage and